NFKB1 and osteoarthritis: For instance, Schisandrin B has been reported to ameliorate chondrocytes inflammation and osteoarthritis by repression of MAPK and NF-κB pathways (Ran et al., 2018), indicating the potential mechanism of its antiinflammation property.